ReferenceRRK5374

Add-Aspirin

A phase III double-blind placebo-controlled randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

Research Summary

Research Overview
PI Name Rea - DW
Speciality
Sponsor University College London
Project Status Open
Proposed End Date 01/07/2024
Study Run through CRF? No
Target number of patients agreed to recruit 66
Recruitment so far 11